Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Yuste

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 31, 2021
Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of ageAbelardo Claudio Fernández Chávez, Luis García Comas, Luis Manzano Espinosa, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2025
Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, SpainJoaquín Llorente, Julio Sempere, Mirella Llamosí, et al.
Emerging Microbes & Infections|June 16, 2025
The rise of serotype 8 is associated with lineages and mutations in the capsular operon with different potential to produce invasive pneumococcal diseaseCovadonga Pérez-García, Aída González-Díaz, Mirian Domenech, et al.
Infection and Immunity|June 11, 2008
Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwayJose Yuste, Ashwin Sen, Lennart Truedsson, et al.
Plos One|September 8, 2012
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strainsElisa Ramos-Sevillano, Cinthya Rodríguez-Sosa, Fabio Cafini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine EraSara de Miguel, Mirian Domenech, Fernando González-Camacho, et al.
Microorganisms|November 27, 2021
Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate VaccinesLucía Fernández-Delgado, Jordi Càmara, Aida González-Díaz, et al.
Plos Pathogens|March 15, 2016
PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal DiseaseElisa Ramos-Sevillano, Ana Urzainqui, Belén de Andrés, et al.
The Lancet. Microbe|August 6, 2022
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance studyJulio Sempere, Mirella Llamosí, Beatriz López Ruiz, et al.
Plos One|August 14, 2010
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis modelFabio Cafini, Jose Yuste, Maria-Jose Giménez, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 31, 2021
Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of ageAbelardo Claudio Fernández Chávez, Luis García Comas, Luis Manzano Espinosa, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2025
Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, SpainJoaquín Llorente, Julio Sempere, Mirella Llamosí, et al.
Emerging Microbes & Infections|June 16, 2025
The rise of serotype 8 is associated with lineages and mutations in the capsular operon with different potential to produce invasive pneumococcal diseaseCovadonga Pérez-García, Aída González-Díaz, Mirian Domenech, et al.
Infection and Immunity|June 11, 2008
Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwayJose Yuste, Ashwin Sen, Lennart Truedsson, et al.
Plos One|September 8, 2012
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strainsElisa Ramos-Sevillano, Cinthya Rodríguez-Sosa, Fabio Cafini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine EraSara de Miguel, Mirian Domenech, Fernando González-Camacho, et al.
Microorganisms|November 27, 2021
Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate VaccinesLucía Fernández-Delgado, Jordi Càmara, Aida González-Díaz, et al.
Plos Pathogens|March 15, 2016
PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal DiseaseElisa Ramos-Sevillano, Ana Urzainqui, Belén de Andrés, et al.
The Lancet. Microbe|August 6, 2022
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance studyJulio Sempere, Mirella Llamosí, Beatriz López Ruiz, et al.
Plos One|August 14, 2010
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis modelFabio Cafini, Jose Yuste, Maria-Jose Giménez, et al.
Pageof 6